The effects of canagliflozin on uric acid and gout in patients with type 2 diabetes in the CANVAS Program
File(s)2019 CANVAS Program Uric Acid Poster.pdf (263.38 KB)
Accepted version
Author(s)
Type
Conference Paper
Date Issued
2019-06-04
Date Acceptance
2019-06-01
Citation
Diabetes, 2019, 68
ISSN
0012-1797
Publisher
American Diabetes Association
Journal / Book Title
Diabetes
Volume
68
Copyright Statement
© 2019 by the American Diabetes Association. http://www.diabetesjournals.org/content/license
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000501366903101&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Source
79th Scientific Sessions of the American-Diabetes-Association (ADA)
Subjects
Science & Technology
Life Sciences & Biomedicine
Endocrinology & Metabolism
Publication Status
Published
Start Date
2019-06-07
Finish Date
2019-06-11
Coverage Spatial
San Francisco, CA